Ojo, Omorogieva ORCID: https://orcid.org/0000-0003-0071-3652, Weldon, Sharon M. ORCID: https://orcid.org/0000-0001-5487-5265, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X and Vargo, Elisabeth J. (2019) The effect of Vitamin D supplementation on glycaemic control in women with Gestational Diabetes Mellitus: A systematic review and meta-analysis of randomised controlled trials. International Journal of Environmental Research and Public Health, 16 (10):1716. ISSN 1661-7827 (Print), 1660-4601 (Online) (doi:10.3390/ijerph16101716)

Preview

PDF (Publisher's PDF - Open Access) 24076 OJO_The_Effect_of_Vitamin_D_Supplementation_on_Glycaemic_Control_in_Women_with_Gestational_Diabetes_Mellitus_(OA)_2019.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Vitamin D deficiency is highly prevalent amongst pregnant women and is linked to a range of adverse complications, including gestational diabetes. However, there is no consensus among researchers regarding the impact of vitamin D supplementation in alleviating adverse effects in gestational diabetes. The objective of this systematic review and meta-analysis was to determine whether supplementation of vitamin D given to women with gestational diabetes can promote glycaemic control. EMBASE and PubMed were searched up to November, 2018. The selection criteria included randomised controlled trials of the effect of vitamin D supplementation (1000–4762 IU/day) on pregnant women with gestational diabetes mellitus. Study data and outcome measures (fasting blood glucose, glycated haemoglobin and serum insulin) were extracted from included studies. Random-effects models were used for meta-analyses. Heterogeneity tests, and analysis of the risk of bias were conducted. Most of the studies were graded as having either low risk or moderate risk of bias although two studies had a high risk of bias in the areas of blinding of participants and personnel, and incomplete outcome data. On the other hand, the heterogeneity statistic (I2) ranged from 0–41% in the studies included. Five randomised controlled trials were selected for this review and meta-analysis (involving a total of 173 participants supplemented with vitamin D and 153 participants as control drawn from the studies). Vitamin D supplementation was associated with a decrease in fasting blood glucose by a mean of 0.46 mmol/L (−0.68, −0.25) (p < 0.001), glycated haemoglobin by a mean of 0.37% (−0.65, −0.08) (p < 0.01) and serum insulin concentration by mean of 4.10 µIU/mL (−5.50, −2.71) (p < 0.001) compared to controls. This review shows evidence that vitamin D supplementation has the potential to promote glycaemic control in women with Gestational Diabetes Mellitus (GDM). However, due to the limited number of studies in the meta-analysis, the conclusion should be interpreted with caution. Further studies are needed to fully understand the exact mechanism by which vitamin D influences glucose metabolism.

Item Type:	Article
Additional Information:	© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Uncontrolled Keywords:	Gestational Diabetes Mellitus; Vitamin D supplementation; meta-analysis; pregnancy; insulin
Subjects:	R Medicine > R Medicine (General)
Faculty / School / Research Centre / Research Group:	Faculty of Education, Health & Human Sciences Faculty of Education, Health & Human Sciences > School of Health Sciences (HEA) Faculty of Education, Health & Human Sciences > Health & Society Research Group
Last Modified:	25 Apr 2020 10:36
URI:	http://gala.gre.ac.uk/id/eprint/24076

Actions (login required)

View Item

Downloads